Anzeige
Mehr »
Montag, 18.08.2025 - Börsentäglich über 12.000 News
Sonntag: Glencores 6,35-Mrd.-€-Deal zeigt, warum dieses 30-Mio.-€-Energie-Junior stark unterbewertet ist!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40NZ0 | ISIN: US46583A3032 | Ticker-Symbol:
NASDAQ
15.08.25 | 20:22
1,700 US-Dollar
-6,08 % -0,110
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
IVEDA SOLUTIONS INC Chart 1 Jahr
5-Tage-Chart
IVEDA SOLUTIONS INC 5-Tage-Chart

Aktueller Chart IVEDA SOLUTIONS Aktie

Chart vergleichen mit:

Firmenname, WKN, ISIN oder Aktien-Kürzel

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%
Chart-Typ:
Zeitraum:
 
IVEDA SOLUTIONS INC-Investoren interessieren sich auch für diese Wertpapiere
EQS-News: Immunic AG: Immunic, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate UpdateIssuer: Immunic AG / Key word(s): Quarter Results Immunic, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update 07.08.2025 / 12:30 CET/CEST The...
► Artikel lesen
Immunic, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update- Vidofludimus Calcium Substantially Reduced 24-Week Confirmed Disability Worsening in Phase 2 CALLIPER Trial in Overall Progressive Multiple Sclerosis Study Population...
► Artikel lesen
EQS-News: Immunic AG: Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple SclerosisIssuer: Immunic AG / Key word(s): Study/Study results Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in...
► Artikel lesen
Applied DNA Sciences, Inc.: Applied DNA Reports Third Quarter Fiscal 2025 Financial ResultsSTONY BROOK, NY / ACCESS Newswire / August 14, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a biotechnology company focused on providing nucleic acid production...
► Artikel lesen
Applied DNA Sciences: Applied DNA Announces New Follow-On LineaDNA Order from Global IVD Manufacturer for Use in Cancer Diagnostic ApplicationSTONY BROOK, NY / ACCESS Newswire / July 24, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in synthetic DNA manufacturing powered by scalable PCR platforms...
► Artikel lesen
Applied DNA Sciences, Inc.: Applied DNA Regains Compliance with All Nasdaq Continued Listing RequirementsSTONY BROOK, NY / ACCESS Newswire / July 7, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (the "Company"), a leader in PCR-based DNA technologies, today announced that on July 2, 2025, it received...
► Artikel lesen
XTI Aerospace, Inc.: XTI Aerospace Reports Second Quarter 2025 Results and Provides Business UpdateStrong TriFan 600 development progress, expanded strategic partnerships and strengthened balance sheet ENGLEWOOD, Colo., Aug. 14, 2025 /PRNewswire/ -- XTI Aerospace...
► Artikel lesen
Aktien-Trading 4 Dummies - 3 Aktien. 2 Experten. 0 Langeweile (Hims & Hers, Teladoc & XTI Aerospace)Anzeige / WerbungAktien-Trading 4 Dummies - 3 Aktien. 2 Experten. 0 Langeweile (Hims & Hers, Teladoc & XTI Aerospace) Fundamentalanalyse trifft auf Charttechnik, so starteten wir diese Webinarreihe...
► Artikel lesen
XTI Aerospace, Inc.: President Trump's Executive Order Highlights the Strategic Importance of VTOL SectorXTI Aerospace expects Trump Executive Order to accelerate VTOL development for commercial and military applications ENGLEWOOD, Colo., June 10, 2025 /PRNewswire/ -- Commending President...
► Artikel lesen